Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-28 5:46 pm Purchase |
2024-10-17 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
PATHSTONE FAMILY OFFICE, LLC | 2,797,661 7.910% |
2,797,661 (New Position) |
Filing History |
| 2025-02-14 10:34 am Purchase |
2024-12-31 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
Meteora Capital, LLC | 2,772,145 7.840% |
2,772,145 (New Position) |
Filing History |
| 2024-08-22 5:22 pm Purchase |
2024-08-12 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
CFIC-2015 NV Family Investments LLC | 4,166,666 13.900% |
4,166,666 (New Position) |
Filing History |
| 2024-05-10 2:42 pm Sale |
2024-05-10 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
Meteora Capital, LLC | 0 0.000% |
-1,596,817 (Position Closed) |
Filing History |
| 2024-02-14 1:05 pm Purchase |
2023-12-31 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
Meteora Capital, LLC | 1,596,817 7.300% |
1,596,817 (New Position) |
Filing History |
| 2024-02-14 06:28 am Sale |
2023-12-31 | 13G | Graf Acquisition Corp. IV GFOR |
Radcliffe Capital Management L.P. | 0 0.000% |
-641,474 (Position Closed) |
Filing History |
| 2024-02-07 07:31 am Unchanged |
2023-12-31 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-12-19 1:41 pm Sale |
2023-12-13 | 13D | NKGen Biotech, Inc. Common Stock NKGN |
NKMAX Co. Ltd. | 12,917,057 53.180% |
-2,453,576 (-15.96%) |
Filing History |
| 2023-10-10 5:01 pm Purchase |
2023-09-29 | 13D | NKGen Biotech, Inc. Common Stock NKGN |
NKMAX Co. Ltd. | 15,370,633 63.400% |
15,370,633 (New Position) |
Filing History |
| 2023-05-23 10:29 am Purchase |
2023-05-23 | 13G | Graf Acquisition Corp. IV GFOR |
Radcliffe Capital Management L.P. | 641,474 6.180% |
641,474 (New Position) |
Filing History |
| 2023-01-25 07:09 am Sale |
2022-12-31 | 13G | Graf Acquisition Corp. IV GFOR |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,124,431 (Position Closed) |
Filing History |
| 2022-02-11 4:10 pm Purchase |
2021-12-31 | 13G | Graf Acquisition Corp. IV GFOR |
Graf Acquisition Partners IV LLC | 4,210,375 19.600% |
4,210,375 (New Position) |
Filing History |
| 2022-02-03 08:19 am Purchase |
2021-12-31 | 13G | Graf Acquisition Corp. IV GFOR |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,124,431 5.240% |
19,784 (+1.79%) |
Filing History |
| 2021-07-09 4:49 pm Purchase |
2021-07-02 | 13G | Graf Acquisition Corp. IV GFOR |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,104,647 5.150% |
1,104,647 (New Position) |
Filing History |
| 2021-06-04 4:05 pm Purchase |
2021-05-25 | 13G | GRAF ACQ CORP IV UNIT 1 COM & GFORU |
ADAGE CAPITAL PARTNERS GP LLC | 1,350,000 6.990% |
1,350,000 (New Position) |
Filing History |